Editas Medicine, Inc. - Common Stock (EDIT)

CUSIP: 28106W103

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / Common Stock
Shares outstanding
82,773,190
Total 13F shares
27,537,538
Share change
+5,055,912
Total reported value
$614,414,843
Put/Call ratio
211%
Price per share
$22.32
Number of holders
99
Value change
+$120,573,551
Number of buys
66
Number of sells
32

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 28106W103?
CUSIP 28106W103 identifies EDIT - Editas Medicine, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of EDIT - Editas Medicine, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
6.6%
5,498,390
$89,239,000 31 Dec 2016
13F
Polaris Venture Management Co. VI, L.L.C.
13F
Company
4.6%
3,797,146
$61,628,000 31 Dec 2016
13F
Flagship Pioneering, LLC
13F
Company
4.2%
3,455,316
$56,080,000 31 Dec 2016
13F
VIKING GLOBAL INVESTORS LP
13F
Company
2.1%
1,709,401
$27,744,000 31 Dec 2016
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
2.1%
1,709,400
$27,744,000 31 Dec 2016
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
2%
1,631,534
$26,480,000 31 Dec 2016
13F
VANGUARD GROUP INC
13F
Company
1.6%
1,316,384
$21,365,000 31 Dec 2016
13F
BlackRock Fund Advisors
13F
Company
0.86%
713,006
$11,572,000 31 Dec 2016
13F
EcoR1 Capital, LLC
13F
Company
0.76%
626,762
$10,172,000 31 Dec 2016
13F
Capital World Investors
13F
Company
0.36%
295,000
$4,788,000 31 Dec 2016
13F
Foresite Capital Management III, LLC
13F
Company
0.33%
274,910
$4,462,000 31 Dec 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0.31%
260,639
$4,230,000 31 Dec 2016
13F
CREDIT SUISSE AG/
13F
Company
0.27%
226,167
$3,670,000 31 Dec 2016
13F
MORGAN STANLEY
13F
Company
0.25%
208,324
$3,381,000 31 Dec 2016
13F
SABBY MANAGEMENT, LLC
13F
Company
0.14%
115,000
$1,866,000 31 Dec 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.14%
113,979
$1,849,000 31 Dec 2016
13F
STATE STREET CORP
13F
Company
0.13%
105,167
$1,708,000 31 Dec 2016
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.11%
94,800
$1,539,000 31 Dec 2016
13F
NORGES BANK
13F
Company
0.11%
91,102
$1,479,000 31 Dec 2016
13F
HIGHLAND CAPITAL MANAGEMENT LP
13F
Company
0.11%
90,000
$1,460,000 31 Dec 2016
13F
NORTHERN TRUST CORP
13F
Company
0.11%
89,538
$1,453,000 31 Dec 2016
13F
Clarius Group, LLC
13F
Company
0.11%
87,231
$1,416,000 31 Dec 2016
13F
Omega Fund Management, LLC
13F
Company
0.08%
66,162
$1,074,000 31 Dec 2016
13F
Casdin Capital, LLC
13F
Company
0.08%
65,000
$1,055,000 31 Dec 2016
13F
CLOUGH CAPITAL PARTNERS L P
13F
Company
0.06%
50,400
$818,000 31 Dec 2016
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.06%
49,619
$806,000 31 Dec 2016
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.06%
46,580
$756,000 31 Dec 2016
13F
Bank of New York Mellon Corp
13F
Company
0.05%
41,429
$672,000 31 Dec 2016
13F
Wildcat Capital Management, LLC
13F
Company
0.05%
41,324
$671,000 31 Dec 2016
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.05%
38,901
$632,000 31 Dec 2016
13F
HARBOURVEST PARTNERS LLC
13F
Company
0.04%
36,362
$590,000 31 Dec 2016
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.04%
34,709
$563,000 31 Dec 2016
13F
TD ASSET MANAGEMENT INC
13F
Company
0.04%
30,970
$503,000 31 Dec 2016
13F
Swiss National Bank
13F
Company
0.04%
30,100
$489,000 31 Dec 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.04%
29,614
$481,000 31 Dec 2016
13F
BlackRock Investment Management, LLC
13F
Company
0.03%
26,397
$428,000 31 Dec 2016
13F
A.R.T. Advisors, LLC
13F
Company
0.03%
25,700
$417,000 31 Dec 2016
13F
ProShare Advisors LLC
13F
Company
0.03%
25,320
$411,000 31 Dec 2016
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.03%
24,200
$393,000 31 Dec 2016
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.03%
22,180
$360,000 31 Dec 2016
13F
BESSEMER GROUP INC
13F
Company
0.03%
21,818
$354,000 31 Dec 2016
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.02%
20,678
$336,000 31 Dec 2016
13F
Squarepoint Ops LLC
13F
Company
0.02%
20,026
$325,000 31 Dec 2016
13F
SG Americas Securities, LLC
13F
Company
0.02%
19,641
$319,000 31 Dec 2016
13F
HAMILTON LANE ADVISORS LLC
13F
Company
0.02%
19,323
$314,000 31 Dec 2016
13F
D. E. Shaw & Co., Inc.
13F
Company
0.02%
18,277
$297,000 31 Dec 2016
13F
Russell Investments Group, Ltd.
13F
Company
0.02%
17,647
$284,000 31 Dec 2016
13F
GROUP ONE TRADING LLC
13F
Company
0.02%
14,818
$241,000 31 Dec 2016
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.02%
14,100
$229,000 31 Dec 2016
13F
BlackRock Group LTD
13F
Company
0.01%
11,650
$189,000 31 Dec 2016
13F

Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q1 2017

As of 31 Mar 2017, Editas Medicine, Inc. - Common Stock (EDIT) was held by 99 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,537,538 shares. The largest 10 holders included FMR LLC, Polaris Venture Management Co. VI, L.L.C., Flagship Pioneering Inc., VANGUARD GROUP INC, Capital World Investors, Viking Global Investors LP, DEERFIELD MANAGEMENT CO, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., and MILLENNIUM MANAGEMENT LLC. This page lists 99 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2017 vs Q4 2016 Across Filers

Q4 2016 holders
84
Q1 2017 holders
99
Holder diff
15
Investor Q4 2016 Shares Q1 2017 Shares Share Diff Share Chg % Q4 2016 Value $ Q1 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.